Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1980 Jun;35(6):428–434. doi: 10.1136/thx.35.6.428

Effect of inhaled H1 and H2 receptor antagonist in normal and asthmatic subjects.

N C Thomson, J W Kerr
PMCID: PMC471304  PMID: 6449094

Abstract

The effects on airflow resistance of an inhaled H1 receptor antagonist, clemastine, and an H2 receptor antagonist, cimetidine, have been investigated in normal and asthmatic subjects. No significant changes in specific conductance (sGaw) were seen in six normal subjects. In eight asthmatic subjects a significant increase in forced expiratory volume in one second (FEV1) occurred at 60 min (< 0.02), and 120 (< 0.05) after the inhalation of clemastine, whereas inhaled cimetidine had no effect on airflow resistance. Clemastine and cimetidine were tested on histamine-induced bronchoconstriction in eight normal and eight asthmatic subjects. Clemastine significantly reduced the fall in sGaw in normal subjects and the fall in FEV1 in asthmatic subjects, whereas cimetidine had no protective effect. Clemastine and ipratropium bromide were tested on methacholine-induced bronchoconstriction in eight normal subjects. Ipratropium bromide, but not clemastine, significantly reduced the fall in sGaw after methacholine. These results suggest that in normal and asthmatic subjects histamine-induced bronchoconstriction is mediated predominantly via H1 rather than H2 receptors in the airways.

Full text

PDF
428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austen K. F., Orange R. P. Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis. 1975 Sep;112(3):423–436. doi: 10.1164/arrd.1975.112.3.423. [DOI] [PubMed] [Google Scholar]
  2. Benson M. K. Bronchial hyperreactivity. Br J Dis Chest. 1975 Oct;69(0):227–239. doi: 10.1016/0007-0971(75)90090-x. [DOI] [PubMed] [Google Scholar]
  3. Bhat K. N., Arroyave C. M., Marney S. R., Jr, Stevenson D. D., Tan E. M. Plasma histamine changes during provoked bronchospasm in asthmatic patients. J Allergy Clin Immunol. 1976 Dec;58(6):647–656. doi: 10.1016/0091-6749(76)90176-7. [DOI] [PubMed] [Google Scholar]
  4. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  5. Black J. W., Owen D. A., Parsons M. E. An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol. 1975 Jul;54(3):319–324. doi: 10.1111/j.1476-5381.1975.tb07571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown N. E., McFadden E. R., Jr, Ingram R. H., Jr Airway responses to inhaled histamine in asymptomatic smokers and nonsmokers. J Appl Physiol Respir Environ Exerc Physiol. 1977 Apr;42(4):508–513. doi: 10.1152/jappl.1977.42.4.508. [DOI] [PubMed] [Google Scholar]
  7. Busse W. W., Sosman J. Decreased H2 histamine response of granulocytes of asthmatic patients. J Clin Invest. 1977 Jun;59(6):1080–1087. doi: 10.1172/JCI108731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Casterline C. L., Evans R., 3rd, Ward G. W., Jr The effect of atropine and albuterol aerosols on the human bronchial response to histamine. J Allergy Clin Immunol. 1976 Nov;58(5):607–613. doi: 10.1016/0091-6749(76)90207-4. [DOI] [PubMed] [Google Scholar]
  9. Casterline C. L., Evans R. Further studies on the mechanism of human histamine-induced asthma: the effect of an aerosolized H1 receptor antagonist (diphenhydramine). J Allergy Clin Immunol. 1977 Jun;59(6):420–424. doi: 10.1016/0091-6749(77)90004-5. [DOI] [PubMed] [Google Scholar]
  10. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Protective effect of drugs on histamine-induced asthma. Thorax. 1977 Aug;32(4):429–437. doi: 10.1136/thx.32.4.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dale H. H., Laidlaw P. P. The physiological action of beta-iminazolylethylamine. J Physiol. 1910 Dec 31;41(5):318–344. doi: 10.1113/jphysiol.1910.sp001406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Drazen J. M., Venugopalan C. S., Soter N. A. H2 receptor mediated inhibition of immediate type hypersensitivity reactions in vivo. Am Rev Respir Dis. 1978 Mar;117(3):479–484. doi: 10.1164/arrd.1978.117.3.479. [DOI] [PubMed] [Google Scholar]
  13. Eyre P. Histamine H2-receptors in the sheep bronchus and cat trachea: the action of burimamide. Br J Pharmacol. 1973 Jun;48(2):321–323. doi: 10.1111/j.1476-5381.1973.tb06920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ferris L., Anderson S. D., Temple D. M. Histamine release in exercise-induced asthma. Br Med J. 1978 Jun 24;1(6128):1697–1697. doi: 10.1136/bmj.1.6128.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gold W. M., Kessler G. F., Yu D. Y. Role of vagus nerves in experimental asthma in allergic dogs. J Appl Physiol. 1972 Dec;33(6):719–725. doi: 10.1152/jappl.1972.33.6.719. [DOI] [PubMed] [Google Scholar]
  16. Nogrady S. G., Bevan C. Inhaled antihistamines--bronchodilatation and effects on histamine- and methacholine-induced bronchoconstriction. Thorax. 1978 Dec;33(6):700–704. doi: 10.1136/thx.33.6.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nogrady S. G., Hartley J. P., Handslip P. D., Hurst N. P. Bronchodilatation after inhalation of the antihistamine clemastine. Thorax. 1978 Aug;33(4):479–482. doi: 10.1136/thx.33.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Popa V. T. Bronchodilating activity of an H1 blocker, chlorpheniramine. J Allergy Clin Immunol. 1977 Jan;59(1):54–63. doi: 10.1016/0091-6749(77)90177-4. [DOI] [PubMed] [Google Scholar]
  19. Powell J. R., Brody M. J. Participation of H1 and H2 histamine receptors in physiological vasodilator responses. Am J Physiol. 1976 Oct;231(4):1002–1009. doi: 10.1152/ajplegacy.1976.231.4.1002. [DOI] [PubMed] [Google Scholar]
  20. Simon R. A., Stevenson D. D., Arroyave C. M., Tan E. M. The relationship of plasma histamine to the activity of bronchial asthma. J Allergy Clin Immunol. 1977 Nov;60(5):312–316. doi: 10.1016/0091-6749(77)90111-7. [DOI] [PubMed] [Google Scholar]
  21. Stevenson D. D., Arroyave C. M., Bhat K. N., Tan E. M. Oral aspirin challenges in asthmatic patients: a study of plasma histamine. Clin Allergy. 1976 Sep;6(5):493–505. doi: 10.1111/j.1365-2222.1976.tb01934.x. [DOI] [PubMed] [Google Scholar]
  22. Thomson N. C. The effect of different pharmacological agents on respiratory reflexes in normal and asthmatic subjects. Clin Sci (Lond) 1979 Mar;56(3):235–241. doi: 10.1042/cs0560235. [DOI] [PubMed] [Google Scholar]
  23. Weidmann H., Grauwiler J., Griffith R., Römer D., Taeschler M., Zehnder K. Farmacologia, farmacocinetica e tossicologia del nuovo antistaminico HS592 (Tavegil) Boll Chim Farm. 1967 Jul;106(7):467–496. [PubMed] [Google Scholar]
  24. Woenne R., Kattan M., Orange R. P., Levison H. Bronchial hyperreactivity to histamine and methacholine in asthmatic children after inhalation of SCH 1000 and chlorpheniramine maleate. J Allergy Clin Immunol. 1978 Aug;62(2):119–124. doi: 10.1016/0091-6749(78)90089-1. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES